Rheumatoid Arthritis Response to Methotrexate
NCT03535519 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2019-08-07
Summary
Observational and prospective study of the ultrasound response to methotrexate in rheumatoid arthritis patients who started methotrexate
Conditions
Interventions
- DRUG
-
Methotrexate
standard of care treatment with methotrexate
Sponsors & Collaborators
-
Nordic Pharma SAS
collaborator INDUSTRY -
Juan Carlos Nieto
lead OTHER
Principal Investigators
-
Juan Carlos Nieto González, PhD · Hospital General Universitario Gregorio Maranon
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-07
- Primary Completion
- 2020-08-31
- Completion
- 2020-08-31
Countries
- Spain
Study Locations
More Related Trials
-
Comparison of Compliance and Evolution of Functional Capacity of Patients With Rheumatoid Arthritis Treated by Methotrexate Either by Auto-injector or by Conventional Sub-cutaneous Syringe
NCT02553018 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis
NCT01975610 ·Status: COMPLETED ·Phase: PHASE2
-
Study Evaluating Multiple Doses Of ATN-103 In Subjects With Active Rheumatoid Arthritis
NCT00959036 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Prospective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
NCT04871919 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Investigate How JNJ-38518168 May Affect the Plasma Levels of Methotrexate in Rheumatoid Arthritis Participants
NCT01450982 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
NCT04038970 ·Status: COMPLETED ·Phase: PHASE2
-
Prospective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
NCT05323591 ·Status: COMPLETED
-
An Ascending Dose Study of PIT565 in Participants With Rheumatoid Arthritis
NCT07029555 ·Status: RECRUITING ·Phase: PHASE1
-
Leflunomide + Methotrexate in Rheumatoid Arthritis
NCT00563849 ·Status: COMPLETED ·Phase: PHASE4
-
Treatment Adherence to Injectable Methotrexate in Rheumatoid Arthritis
NCT02897817 ·Status: COMPLETED
-
A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Certolizumab Pegol in Combination With Methotrexate in the Treatment of Disease Modifying Antirheumatic Drugs (DMARD)-naïve Adults With Early Active Rheumatoid Arthritis
NCT01519791 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)
NCT00482417 ·Status: COMPLETED ·Phase: PHASE2
-
Applications for Methotrexate Optimization in Rheumatoid Arthritis
NCT01038349 ·Status: COMPLETED
-
Safety and Effectiveness of Acthar Gel in Participants With Rheumatoid Arthritis
NCT02919761 ·Status: COMPLETED ·Phase: PHASE4
-
Methotrexate Use Improvement in Rheumatoid Arthritis Using Biomarker Feedback
NCT03913728 ·Status: COMPLETED ·Phase: NA
-
Methotrexate Withdrawal Study of Tofacitinib Modified Release Formulation in Subjects With Rheumatoid Arthritis
NCT02831855 ·Status: COMPLETED ·Phase: PHASE4
-
Oral CF101 Tablets and Methotrexate Treatment in Rheumatoid Arthritis Patients
NCT00556894 ·Status: COMPLETED ·Phase: PHASE2
-
A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis
NCT01462162 ·Status: COMPLETED
-
Dose-Escalating Multiple Dose Study of PD-0360324 in Combination With Methotrexate in Patients With Rheumatoid Arthritis
NCT00550355 ·Status: COMPLETED ·Phase: PHASE1
-
Ultrasound as Imaging Biomarker of Early Response to Tocilizumab and Methotrexate in Very Early Rheumatoid Arthritis
NCT02837146 ·Status: UNKNOWN ·Phase: PHASE3
-
Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid Arthritis
NCT00867516 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of CDP870 and Methotrexate Compared to Methotrexate Alone in Subjects With Rheumatoid Arthritis
NCT00544154 ·Status: COMPLETED ·Phase: PHASE3
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Dose CFZ533 in Rheumatoid Arthritis Patients
NCT02089087 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 2 Study to Evaluate the Efficacy and Safety of 60mg of MM-093 in Patients With Active Rheumatoid Arthritis
NCT00458146 ·Status: COMPLETED ·Phase: PHASE2
-
A Safety & Efficacy Study of Treatment With AP1189 in Rheumatoid Arthritis Patients naïve to DMARD Treatment
NCT05516979 ·Status: COMPLETED ·Phase: PHASE2